$MRSN

2.28.19 Secondary Announcement

This content is restricted to IPO Boutique Subscribers Username or E-mail: Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual[…]

Mersana Therapeutics, Inc. IPO Preview

Company: Mersana Therapeutics, Inc. Symbol: MRSN Description They are a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. Shares: 5 million Price Range: $14.00-$16.00 Trade Date: 6/28 Underwriter(s): J.P. Morgan, Cowen and Company, Leerink Partners Co-Manager: Wedbush PacGrow[…]

Healthcare in spotlight for busy final week of June

SIGN UP FOR IPO BOUTIQUE’S FREE NEWSLETTER There are ten IPOs on the schedule for this week including five healthcare offerings. Below is the IPO schedule for the upcoming week: Tuesday – 6/27 Avenue Therapeutics (Nasdaq: ATXI) is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl,[…]

New Filings & Updated Terms – Week Ending 6.2.17

IPO Boutique keeps apprised of the active pipeline. Currently there are 61 active IPOs in the pipeline as of June 2, 2016. No SPACs or Unit Offerings are included.   NEW FILINGS Company: Byline Bancorp, Inc. Symbol: BY Description: They are a bank holding company headquartered in Chicago, Illinois and conduct all our business activities[…]

Scroll to top
error: Content is protected !!